Global Market For Cake to Witness Tremendous Growth and Expansion by 2030

 Cake Market Growth & Trends

The global cake market size was anticipated to reach USD 80.42 billion by 2030 and it is projected to grow at a CAGR of 3.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increase in e-commerce platforms has made it easier for consumers to access a wide variety of cakes, from cupcakes, muffins, and sheet cakes to cheesecakes. In addition, manufacturers are launching innovative cake options like gluten-free, sugar-free, and organic to cater to evolving consumer tastes and preferences. These factors are expected to drive the demand for cakes during the forecast period.

The online platform serves as a powerful showcase for the creativity of cake artisans. E-commerce websites and social media platforms provide a visual feast, allowing cake businesses to display their intricate designs and assorted flavors. This virtual storefront attracts local customers and captures the attention of a broader online audience searching for unique and visually appealing cakes. The ability to showcase products through high-quality images and detailed descriptions enhances the overall customer experience, enticing them to explore and indulge in the offerings.

The rise of personalized and customizable cake options is another opportunity e-commerce has facilitated within the global market. Online platforms often provide user-friendly interfaces that allow customers to tailor their cake orders according to specific preferences, from flavors and fillings to designs and decorations. This level of personalization enhances customer satisfaction and encourages repeat business as individuals seek to create unique experiences for various occasions.

The dessert cakes segment held the largest market size in 2023. Consumers are increasingly seeking unique and visually appealing dessert options, and cake manufacturers are responding by introducing creative and gourmet flavors, textures, and designs. This emphasis on innovation contributes to the dynamism of the market, keeping it vibrant and adaptable to changing consumer trends.

Asia Pacific held the largest revenue share of the market. The Asia Pacific region's population exhibits diverse tastes and preferences, and consumers in this region are known for their willingness to experiment with various flavors, ingredients, and food formats. In response to this, manufacturers operating in the food industry consistently innovate and constantly expand and diversify their product portfolios. The rising acceptance of convenience foods is a significant factor contributing to the growth of Asia's market. The fast-paced and hectic lifestyles of consumers in this region have led to an increased demand for convenient food products that are quick to prepare and easy to consume.

Request a free sample copy or view report summary: Cake Market Report

Cake Market Report Highlights

• Based on product, the cupcakes segment is expected to grow at the fastest CAGR of 4.3% from 2024 to 2030. Cupcakes offer convenient single serving sizes, versatility in flavors and decorations, and appeal for special occasions, which is expected to drive the segment growth during the forecast period
• Based on distribution, cake sales through the foodservice segment is expected to grow at the fastest CAGR of 3.7% from 2024 to 2030. The expansion of the foodservice industry, including restaurants, cafes, and catering services, coupled with the rising trend of including cakes on their menus, is expected to drive the market growth during the forecast period
• Central & South America is expected to grow at the fastest CAGR of 3.2% from 2024 to 2030. The rise of modern supermarkets and bakery chains across the region has made cakes more readily available and accessible to consumers. Furthermore, cakes are now enjoyed more casually as part of everyday life and are not limited to being primarily consumed during festive occasions, which drives the market growth in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cake-market

Cake Market Segmentation

Grand View Research has segmented the global cake market based on product, distribution channel, and region:

Cake Product Outlook (Revenue, USD Million, 2018 - 2030)

• Cupcakes
• Sponge Cakes
• Dessert Cakes
• Others

Cake Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Foodservice
• Retail
  • Hypermarkets & Supermarkets
  • Specialty Stores
  • Online
  • Others

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
• South America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players in the Cake Market

• Pepperidge Farm (Campbell Soup Company)
• Bimbo Bakeries USA (Grupo Bimbo)
• Hostess Brands, Inc.
• McKee Foods
• Balconi S.p.A.
• Monginis
• Merwans Confectioners Pvt. Ltd
• Britannia Industries Limited
• Bake’n Joy Foods, Inc.
• Bonn

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Point Of Entry Water Treatment Systems Market is Expected to Enhance $13.42 Billion Revenue By 2030: Grand View Research Inc.

 Point Of Entry Water Treatment System Market Growth & Trends

The global point of entry water treatment systems market size is anticipated to reach USD 13.42 billion by 2030 and is anticipated to expand at a CAGR of 4.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rise in awareness regarding water contamination due to lead, bacteria, and chemical, micro-plastic contents is expected to fuel product demand. Other factors driving product demand include growing population, strong economic growth, rising number of household constructions, increasing disposable income, and high product awareness among consumers. The increasing levels of contamination have resulted in the rising product adoption, thereby boosting industry growth. The introduction of new technologies and incorporation of the IoT in the newly launched products are also likely to contribute to market growth. For instance, In March 2023, DuPont launched DuPont Multibore PRO and PES ultrafiltration membranes.

Customers who want to reduce the distress of modules required in water purification systems can use Multibore PRO, which acts as part of a multi-technology approach to water treatment applications in various sectors. Increasing collaboration activities among industry experts and market players are facilitating the introduction of innovative products. Manufacturers are also collaborating with governments of various countries to cater to specific needs based on the water quality and presence of pollutants in the water in the region. For instance, in July 2020, DuPont Water Solutions and Kenya Integrated Water, Sanitation and Hygiene (KIWASH) formed a cooperative project in Kenya to commission the installation of a water filtration system, which will purify drinking water by removing fluoride ions.

Request a free sample copy or view report summary: Point Of Entry Water Treatment Systems Market Report

Point Of Entry Water Treatment Systems Market Report Highlights

• Based on technology, the reverse osmosis (RO) systems segment held a prominent share of more than 16.2% in 2023 owing to widespread awareness about the RO water treatment capabilities
• Based on technology, the distillation systems segment is expected to grow at the lucrative CAGR over the forecast period
• The industrial application segment held the largest market share of 48.6% in 2023. The commercial application segment is anticipated to witness the fastest growth from 2024 to 2030
• Rising water scarcity and increasing levels of industrial, pharmaceutical, and other hazardous chemical pollutants are augmenting product adoption and installation
• Asia pacific dominated the industry in 2023 owing to factors, such as increasing construction activities, rising health consciousness, and high awareness regarding waterborne illness
• In December 2023, Watts formed an agreement to acquire Josam Company, a manufacturer of plumbing and drainage products. This acquisition will expand sales networks and provide increased cross-selling opportunities to the former

Access Press Release@ https://www.grandviewresearch.com/press-release/global-point-entry-water-treatment-systems-market

Point Of Entry Water Treatment Systems Market Report Segmentation

Grand View Research has segmented the global point of entry water treatment systems market on the basis of technology, application, and region:

Point Of Entry Water Treatment Systems Technology Outlook (Revenue, USD Billion, 2018 - 2030)

• Reverse Osmosis Systems
• Water Softeners
• Disinfection Methods
• Filtration Methods
• Distillation Systems
• Others

Point Of Entry Water Treatment Systems Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Residential
• Commercial
  • Offices
  • Hotels
  • Restaurants
  • Café
  • Hospitals
  • Schools
  • Other
• Industrial

Point Of Entry Water Treatment Systems Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Russia
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Point Of Entry Water Treatment Systems Market

• 3M
• DuPont
• Pentair plc
• BWT Holding GmbH
• Culligan
• Watts
• Aquasana, Inc.
• Calgon Carbon Corporation
• EcoWater Systems LLC
• GE Appliances

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Herpes Simplex Virus Treatment Market To Benefit from Increased Global Uptake of 2024 By 2030

 Herpes Simplex Virus Treatment Market Growth & Trends

The global herpes simplex virus treatment market size is expected to reach USD 4.08 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.1% from 2024 to 2030. The growth of the market is attributed to factors such as increasing prevalence of herpes infection among the population, growing awareness about the disease globally, rising geriatric and immunocompromised population, and an increasing demand to develop novel treatment options to meet the demand for herpes infection therapeutics. Moreover, public-private initiatives are further expected to fuel the growth of the market.

According to the WHO, in 2020, nearly 491.5 million people were suffering from genital herpes caused by the herpes simplex virus 2, and several billion people have herpes simplex virus 1 infection. Although the infection is typically asymptomatic, those who have it are capable of easily transmitting the virus to another person through contact. Furthermore, nearly 80 percent of the global population is a carrier of herpes. This is creating an opportunity for the growth of herpes infection treatment drugs.

Research initiatives and increasing collaborations between research organizations are facilitating the development of novel treatment alternatives against viruses, which is anticipated to boost market growth. In January 2020, a research collaboration between scientists from the EPFL in Lausanne, Switzerland, the University of Geneva (UNIGE), and the University of Manchester led to the development of novel antiviral materials, virucides, made from sugar that show promise for the treatment of herpes simplex (cold sore virus). The development of virucides from sugar has facilitated the arrival of an innovative antiviral drug, which aids treatment without being toxic to humans.

Key players operating in the market are focusing on developing novel and innovative products to meet the increasing demand for providing effective therapeutics. With the increasing demand for effective therapeutics, companies are engaged in developing novel and innovative medicines against infection. For instance, in July 2021, a Phase III study of pritelivir, a novel drug by AiCuris Anti-infective Cures AG, which is a German pharmaceutical company, was commenced, post receiving encouraging Phase II interim results from the Phase II/III trial. This leading compound is developed to treat immunocompromised patients with mucocutaneous HSV infections that are acyclovir-resistant. It was granted Breakthrough Therapy Designation by the U.S. FDA in June 2020. The regulatory support for innovative therapies is projected to improve the number of new drugs entering the market, facilitating enhanced treatment rates, and thereby accelerating market growth. 

Request a free sample copy or view report summary: Herpes Simplex Virus Treatment Market Report

Herpes Simplex Virus Treatment Market Report Highlights

• By treatment, the HSV-1 segment held the largest share in 2023 owing to the high prevalence of infection
• By drug, the acyclovir segment is expected to grow at the fastest rate during the forecast period due to the effectiveness and availability of acyclovir as an oral and topical formulation
• By vaccine, the simplirix segment is expected to grow at the fastest rate during the forecast period as it is the only vaccine available showing promising results as a vaccine candidate
• North America dominated the global market in 2023 owing to the increasing awareness regarding STDs and the rise in healthcare expenditure

Access Press Release@ https://www.grandviewresearch.com/press-release/global-herpes-simplex-virus-treatment-market

Herpes Simplex Virus Treatment Market Segmentation

Grand View Research has segmented the global herpes simplex virus treatment market based on type, drug, vaccine, route of administration, end-use, and region:

Herpes Simplex Virus Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)

• Herpes Simplex Virus-1 (HSV-1)
• Herpes simplex virus-2 (HSV-2)

Herpes Simplex Virus Treatment Drug Outlook (Revenue, USD Million, 2018 - 2030)

• Acyclovir
• Valacyclovir
• Famciclovir
• Other Drugs

Herpes Simplex Virus Treatment Vaccine Outlook (Revenue, USD Million, 2018 - 2030)

• Simplirix
• Others

Herpes Simplex Virus Treatment Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Oral
• Injectable
• Topical

Herpes Simplex Virus Treatment End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Herpes Simplex Virus Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Norway
  • Sweden
  • Denmark
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in Herpes Simplex Virus (HSV) Treatment Market

• GSK plc
• Emcure Pharmaceuticals Ltd.
• Carlsbad Tech
• Glenmark Pharmaceuticals Inc.
• Viatris, Inc.
• Fresenius Kabi AG
• Teva Pharmaceuticals Industries Ltd.
• Apotex Inc.
• Sanofi
• Novartis AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Mycoplasma Testing Market Size, Share, Trends, Analysis And Growth Forecast To 2030: Grand View Research Inc.

 Mycoplasma Testing Market Growth & Trends

The global mycoplasma testing market size is expected to reach USD 2.26 billion by 2030, registering a CAGR of 13.58% over the forecast period, according to a new report by Grand View Research, Inc. The major factors driving the expansion of market includes growing demand for mycoplasma testing in biomanufacturing, emerging economies, and growing pharmaceutical outsourcing. Additionally, the market's overall growth is driven by rising cell-line contamination and innovation & research in biological sciences.

Growing number of government initiatives to support pharmaceutical and biotechnology companies is also driving the market growth. The U.S. FDA proposed to remove a test for detecting mycoplasma within in vitro living cell cultures, as it can help identify only a single test method. These changes in biologics regulations are anticipated to improve specificity and sensitivity in mycoplasma detection tests, leading to introduction of new technologies in the industry. This is expected to create immense opportunities for key players in new product development.

The rates of M. pneumoniae positivity sharply decreased during the COVID-19 pandemic outbreak at the end of 2019. This was a result of the COVID-19 pandemic's stringent regulations, which successfully stopped the spread of M. pneumonia. However, it is anticipated that M. pneumonia will expand even more throughout the research period following the relaxation of COVID-19 limits, which will have a positive impact on the mycoplasma testing market's growth.

Increasing investments in R&D have contributed significantly to the market’s revenue growth. With rising healthcare expenditure, research activities in the life sciences industry are increasing significantly. The adoption of new technologies for drug discovery & development and innovations in cell culture technologies are driving the demand for mycoplasma tests. The high risk of cell culture contamination remains the primary factor expected to drive the mycoplasma testing market over the forecast period

Mycoplasma is estimated to contaminate around 15%-35% of all continuous cell cultures around the world. Out of over 190 known species of mycoplasma, only eight species are responsible for more than 95% of cell culture contamination. Poor cultural practices, aerosols, dust, and cross-contamination as a result of faulty or broken laminar flow are some of the factors responsible for an increase in the number of cell culture contamination events. Such factors are likely to drive the market demand for mycoplasma testing solutions.

Request a free sample copy or view report summary: Mycoplasma Testing Market Report

Mycoplasma Testing Market Report Highlights

• By product, kits and reagents dominated the market, and are anticipated to exhibit the fastest CAGR throughout the forecast period, due to their widespread use in mycoplasma testing
• Ease of conducting the procedure and rapid detection are some of the major advantages offered by the PCR method
• By application, the cell line testing segment held a largest share of 41.65% in 2023, owing to the increase in research projects being done in the field of cell culture
• Mycoplasma contamination can cause alterations in cell culture metabolites and lead to development of toxins. This increases the importance of cell line testing and authentication in the pharmaceutical and biopharmaceutical industries
• North America held the largest share of 39.04% in 2023. This is mostly attributed to the presence of significant market participants, as well as rising R&D spending and federal assistance
• In Asia Pacific, the market is expected to grow at the highest rate in a projected time period driven by factors such as the rising prevalence of target diseases with an aging population, rising awareness and others

Access Press Release@ https://www.grandviewresearch.com/press-release/global-mycoplasma-testing-market

Mycoplasma Testing Market Segmentation 

Grand View Research has segmented the global mycoplasma testing market on the basis of product, technology, application, end-use, and region:

Mycoplasma Testing Product Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments
• Kits & Reagents
  • PCR Assays
  • Nucleic Acid Detection Kits
  • Stains
  • Elimination Kits
  • Standards & Controls
  • Others
• Services

Mycoplasma Testing Technology Outlook (Revenue, USD Million, 2018 - 2030)

• PCR
• ELISA
• Direct Assay
• Indirect Assay
• Microbial Culture Techniques
• Enzymatic Methods

Mycoplasma Testing Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cell Line Testing
• Virus Testing
• End of Production Cells Testing
• Others

Mycoplasma Testing End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Academic Research Institutes
• Cell Banks
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Others

Mycoplasma Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
  • Spain
  • France
  • Italy
  • Denmark
  • Sweden
  • Norway
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in Mycoplasma Testing Market

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Lonza Group AG
• Charles River Laboratories International, Inc.
• PromoCell GmbH
• American Type Culture Collection
• Asahi Kasei Medical Co., Ltd.
• Sartorius AG
• InvivoGen
• Eurofins Scientific

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pharmaceutical Packaging Equipment Market Witness Excellent Revenue Growth During 2024-2030: Grand View Research Inc

 Pharmaceutical Packaging Equipment Market Growth & Trends

The global pharmaceutical packaging equipment market size is anticipated to reach USD 8.69 billion by 2030 and expand at a CAGR of 5.8% during the forecast period, according to a new report by Grand View Research, Inc. The rapid growth in the pharmaceutical industry and the growing demand for drug delivery devices are expected to propel the demand for market in the coming years.

According to the European Federation of Pharmaceutical Industries & Associations, the global pharmaceutical market was valued at USD 1.47 trillion in 2020 and is expected to reach USD 2.23 trillion by 2028, propelling at a significant growth rate. The burgeoning growth of the pharmaceutical industry has become a pivotal driver for the escalating demand in the market. As the pharmaceutical sector expands globally, propelled by increasing healthcare needs, rising chronic diseases, and advancements in medical research, there is a parallel surge in the demand for efficient and sophisticated packaging solutions.

Furthermore, pharmaceutical packaging equipment plays a crucial role in ensuring the safety, integrity, and compliance of pharmaceutical products, meeting the stringent regulations imposed by health authorities. The need for innovative packaging solutions, including blister packaging, bottle filling, and labeling machinery, is intensifying to cater to diverse pharmaceutical formulations. This symbiotic relationship between the pharmaceutical and packaging industries underscores the significance of packaging equipment in safeguarding the efficacy of medicines while facilitating the seamless distribution and delivery of healthcare products worldwide.

The increasing demand for drug delivery devices and blister packaging in developing nations is poised to emerge as a significant driver for the pharmaceutical industry. Advanced drug delivery systems offer notable advantages over traditional methods, including enhanced efficiency, convenient administration routes, improved targeting, reduced toxic metabolites, prolonged drug activity, and reduced margin for error. These advantages and continuous advancements in targeted drug delivery facilitate localized disease treatment with minimal impact on surrounding healthy cells. As a result, these factors are anticipated to contribute significantly to the growth of the global drug delivery devices market, consequently boosting the pharmaceutical packaging market in the foreseeable future.

Request a free sample copy or view report summary: Pharmaceutical Packaging Equipment Market Report

Pharmaceutical Packaging Equipment Market Report Highlights

• The filling segment dominated the machine type segment with a 35.6% share in 2023 due to streamlining the production process by precisely and efficiently dispensing pharmaceutical formulations into various containers such as vials, bottles, and syringes
• Filling machines ensure accuracy in dosage, maintain sterility, and comply with stringent regulatory standards, guaranteeing the integrity and safety of pharmaceutical products
• The wrapping machine segment is expected to grow at the fastest CAGR over the forecast period
• Research-based pharmaceutical companies, especially in Europe and North America, continually invest in development and introduction of new drug delivery systems. It has led to continuous mergers and profitable partnerships between major pharmaceutical companies
• Transdermal technologies such as needle-free devices alone have opened new avenues for pharmaceutical partners seeking to create delivery mechanisms for existing molecules with no viable delivery systems. It may boost the drug delivery devices market over the forecast period, fueling the pharmaceutical packaging market in the coming years
• Asia Pacific dominated the market owing to the expansion of the pharmaceutical sector in the region, especially in the developing economies of Asia Pacific
• In August 2023, MULTIVAC Group inaugurated a new production facility in India, representing a substantial investment of approximately USD 9.8 million. The state-of-the-art building complex, encompassing 10,000 square meters for sales and production, is slated to commence operations in early 2024. Initially, the site will employ around 60 individuals. The primary objective is to enhance customer service in India, Sri Lanka, and Bangladesh by leveraging regional proximity and reducing delivery times

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pharmaceutical-packaging-equipment-market

Pharmaceutical Packaging Equipment Market Segmentation

Grand View Research has segmented the global pharmaceutical packaging equipment market based on machine type and region:

Pharmaceutical Packaging Equipment Machine Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Filling
• Labelling
• Form Fill & Seal
• Cartoning
• Wrapping
• Palletizing
• Cleaning
• Others

Pharmaceutical Packaging Equipment Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • Russia
  • UK
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • South Korea
  • Australia
  • India
• Central & South America
  • Brazil
• Middle East & Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Pharmaceutical Packaging Equipment Market

• Robert Bosch
• Romaco Holding
• Marchesini Group
• Korber AG
• M.A. Industria Macchine Automatiche S.p.A.
• Uhlmann Group
• Accutek Packaging Equipment Companies
• Bausch + Ströbel
• Coesia
• Vanguard Pharmaceuticals Equipment
• MULTIVAC Group
• OPTIMA Packaging Group
• ACG Worldwide
• BREVETTI CEA S.P.A

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Organic Personal Care Ingredients Market: Precise Analysis on Business Overview, Product Scope And Ongoing Market Development 2030

 Organic Personal Care Ingredients Market Growth & Trends

The global organic personal care ingredients market is estimated to reach USD 15.18 billion by 2030 and is anticipated to expand at a CAGR of 5.4% during the forecast period, according to a new report by Grand View Research, Inc. This growth is attributed to the increasing demand for personal and skin care products.

The market is likely to witness tremendous growth over the forecast period on account of the rising awareness about the various health benefits of these products as compared to their synthetic counterparts. Ascending demand for chemical-free products has contributed to the growth of organic and skin care products. The rise in consumer disposable income coupled with changing lifestyles has also contributed to the growth over the past few years.

Furthermore, the rise of social media and the widespread availability of information have empowered consumers to become more discerning about the products they use, leading to a heightened interest in understanding the composition and sourcing of products. This has prompted a notable shift in purchasing behavior, with consumers actively seeking out products that prioritize organic and natural products.

Manufacturers such as L’Oréal; Oriflame; and L’Occitane have been investing heavily in the research and development of more products containing substances that are used in aromatherapy products. This has resulted in a rise in the demand for products over the past few years, which is expected to continue over the forecast period. Emerging economies such as India and China have registered tremendous growth in the demand for such products over the past few years owing to the growing awareness about the ill effects of synthetic products and rising standards of living.

Request a free sample copy or view report summary: Organic Personal Care Ingredients Market Report

Organic Personal Care Ingredients Market Report Highlights

• Organic products dominated the product segment with more than 61.8% share in 2023. Growing consumer awareness about synthetic chemicals used in personal care products and toiletries is expected to propel the organic ingredients over the forecast years
• The hair care application segment is expected to grow at the fastest CAGR over the forecast period
• North America dominated the market. This is expected to promote the incorporation of natural components in products, favoring market growth over the forecast period in the region
• In January 2023, Ashland announced its natural line for personal care, featuring hyalurotech, a sodium hyaluronate bioengineered using biotechnology

Access Press Release@ https://www.grandviewresearch.com/press-release/global-organic-personal-care-ingredients-market

Organic Personal Care Ingredients Market Segmentation

Grand View Research has segmented the global organic personal care ingredients market based on type, product, application, and region:

Organic Personal Care Ingredients Type Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Organic
• Natural

Organic Personal Care Ingredients Product Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Natural Surfactants
• Emollients
• Active Ingredients
• Sugar Polymers
• Natural Preservatives
• Others

Organic Personal Care Ingredients Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Skin Care
• Oral Care
• Hair Care
• Cosmetics
• Others

Organic Personal Care Ingredients Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
  • India
• Central & South America
  • Brazil
• Middle East and Africa

List of Key Players in the Organic Personal Care Ingredients Market

• BASF SE
• AkzoNobel
• CLARIANT
• Evonik Industries
• Agrana Beteiligungs-AG
• Cargill, Inc.
• Croda International plc
• Galaxy Surfactants Ltd.
• GatteFosse SAS
• The Lubrizol Corporation
• Ashland, Inc.
• Silab
• Solvay
• Symrise AG
• Vivimed Labs Ltd
• Rita McQueen Products
• Alban Muller International SAS
• Lucas Meyer Cosmetics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Plastic Resins Market to Expand at a CAGR of 4.5% Through 2030: Grand View Research Inc.

 Plastic Resins Market Growth & Trends

The global plastic resins market size is expected to reach USD 975.4 billion by 2028, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 4.2% over the forecast period. Increasing product consumption in construction, automotive, and electrical & electronics applications is expected to propel the market growth. Regulatory intervention to reduce gross vehicle weight to improve fuel efficiency, as well as to reduce carbon emissions, has driven automotive OEMs to adopt resins as a substitute to steel and aluminum for fabricating automotive components. This, in turn, will boost the market growth.

Favorable federal regulations laid down by agencies, such as the National Highway Traffic Safety Administration and Environmental Protection Agency (EPA), regarding carbon emissions, along with the EU initiatives to develop plastics application for creating lightweight and fuel-efficient cars, are likely to augment the growth of the global market. However, the ongoing health crisis and lockdown imposed by various governments to contain the spread of the coronavirus have led to a decline in product consumption, adversely affecting the overall market growth.

Stringent regulations pertaining to recyclability and depletion of conventional materials, such as metal and wood, are expected to push the product demand in pipes, windows, cables, storage tanks, and other applications in the construction industry. Plastics are durable and cost- & energy-efficient material, which promotes their application in construction applications. The crystalline resin segment accounted for the highest revenue share of over 61% in 2020 and is projected to retain the leading position throughout the forecast period. The segment mainly includes epoxy, Polyethylene (PE), and Polypropylene (PP) resins.

Request a free sample copy or view report summary: Plastic Resins Market Report

Plastic Resins Market Report Highlights

• The global market was valued at USD 711.0 billion in 2020 and is estimated to grow at a CAGR of 4.2% from 2021 to 2028
• China accounted for the maximum revenue share of 33.0% in 2020 due to increased consumer disposable income and demand for luxury cars
• The advent of bio-based plastic resins has played a prominent role in boosting product usage in food & beverage and pharmaceutical applications
• Polymers, such as PET and PC, are widely utilized in beverage packaging and the consumer goods sector
• The global market is highly competitive and fragmented with the presence of various regional and global players

Access Press Release@ https://www.grandviewresearch.com/press-release/global-plastic-resins-market

Plastic Resins Market Segmentation

Grand View Research has segmented the global plastic resins market on the basis of product, application, and region:

Plastic Resin Product Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2028)

• Crystalline Resin
  • Epoxy
  • Polyethylene
  • Polypropylene
• Non-crystalline Resin
  • Polyvinyl Chloride (PVC)
  • Polystyrene (PS)
  • Acrylonitrile Butadiene Styrene (ABS)
  • Polymethyl Methacrylate (PMMA)
• Engineering Plastic
  • Nylon
  • Polybutylene Terephthalate (PBT)
  • Polycarbonate (PC)
  • Polyamide
• Super Engineering Plastic
  • Polyphenylene Sulfide (PPS)
  • Polyether Ether Ketone (PEEK)
  • Liquid Crystal Polymer (LCP)

Plastic Resin Application Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2028)

• Packaging
  • Food
  • Beverage
  • Medical
  • Retail
  • Others
• Automotive
• Construction
• Electrical & Electronics
  • OA Equipment and Home Appliances
  • Electronic Materials
  • Others
• Logistics
• Consumer Goods
• Textiles & Clothing
  • Clothing
  • Industrial use
  • Others
• Furniture & Bedding
• Agriculture
• Medical Devices
• Others

Plastic Resin Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Poland
  • Spain
• China
• Asia
  • India
  • Japan
  • Thailand
  • Malaysia
  • Indonesia
  • Vietnam
  • Singapore
  • Philippines
• Pacific
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • United Arab Emirates (UAE)
  • Oman

List of Key Players of Plastic Resins Market

• BASF SE
• SABIC
• Dow, Inc.
• Evonik Industries AG
• Sumitomo Chemical
• Arkema
• Celanese Corp.
• Eastman Chemical Company
• Chevron Phillips Chemical Co., LLC
• Lotte Chemical Corp.
• Covestro AG
• Toray Industries, Inc.
• Teijin Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biological Safety Testing Products And Services Market Growth in the Coming Years

 Biological Safety Testing Products And Services Market Growth & Trends

The global biological safety testing products and services market size is expected to reach USD 9.30 billion by 2030, registering a CAGR of 10.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is predominantly driven by the increasing production of biologics, boosting the demand for highly effective biological safety testing tools. The increasing disease burden is expected to be a major factor responsible for the rising production of biologics, thereby propelling the market growth.

The increasing prevalence of chronic diseases associated with lifestyle, including diabetes and cancer, is a key factor contributing to the rise in drug development and subsequent commercialization. This is expected to increase the need for ensuring & scrutinizing the safety of specialized and targeted therapies, evaluating outcomes, and circumventing probable shortcomings. In addition, biotechnology and pharmaceutical companies are increasingly integrating biological safety testing products and services to produce contamination-free and highly potent biologics to cater to the large number of people suffering from target diseases. Safety testing for viral conditions is proving to be one of the primary concerns of most companies as it is a critical component of manufacturing, chemistry, and control of biologics. This is fueling growth opportunities in the market.

Laboratory-based contamination is leading to the development and refinement of workstations by incorporating biological safety products and services. The increasing need to work with tissue cultures, maintain the sterility of cell lines, and minimize cross-contamination has increased concerns regarding product integrity. Rising involvement by government healthcare organizations for implementing good manufacturing practices and subsequent testing & control at every production stage is expected to widen the scope for growth.

Furthermore, key players operating in the biological safety testing product & services market are constantly focusing on developing novel products and technologies, further expanding their product portfolio, and to meet the rising demand for biological safety testing globally. For instance, in December 2022, -Charles River Laboratories International, Inc. announced the launch of Endosafe Nexus 200, a fully robotic instrument capable of processing both complex or undiluted, serial dilutions for water, in-process, and final product testing, further expanding its endotoxin testing portfolio. The incorporation of automation through robotics has enabled streamlining the quality control process and subsequently improving overall process efficiency.

Request a free sample copy or view report summary: Biological Safety Testing Products And Services Market Report

Biological Safety Testing Products And Services Market Report Highlights

• Based on product, the reagents and kits segment held a leading revenue share of over 39.9% in 2023, due to their extensive use in research and clinical laboratories
• Based on application, the vaccines & therapeutics segment dominated in terms of market share in 2023 and is anticipated to grow at fastest growth rate owing to the increase in disease outbreaks over the years
• Based on test type, the endotoxin tests segment dominated in terms of the market share of in 2023, owing to the rising prevalence of bacterial infections
• North America dominated the overall market with a revenue share of 35.13% in 2023, owing to rising research investments in biotechnology and the growing burden of chronic diseases. This anticipates increasing the demand for molecular cytogenetics in the region over the forecast period
• Asia Pacific is anticipated to grow at the fastest growth rate over the forecast period due to growing healthcare spending and the development of healthcare infrastructure in developing countries like India and China

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biological-safety-testing-market

Biological Safety Testing Products And Services Market Segmentation

Grand View Research has segmented the global biological safety testing products and services market on the basis of product, application, test type, and region:

Biological Safety Testing Products And Services Product Outlook (Revenue, USD Million, 2018 - 2030)

• Reagents & Kits
• Instruments
• Services

Biological Safety Testing Products And Services Application Outlook (Revenue, USD Million, 2018 - 2030)

• Vaccines & Therapeutics
  • Vaccines
  • Monoclonal Antibodies
  • Recombinant Protein
• Blood & Blood-based Products
• Gene Therapy
• Tissue & Tissue-based Products
• Stem Cell

Biological Safety Testing Products And Services Test Type Outlook (Revenue, USD Million, 2018 - 2030)

• Endotoxin Tests
• Sterility Tests
• Cell Line Authentication & Characterization Tests
• Bioburden Tests
• Adventitious Agent Detection Tests
• Residual Host Contamination Detection Tests
• Others

Biological Safety Testing Products And Services Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Biological Safety Testing Products And Services Market

• Charles River Laboratories
• BSL Bioservice
• Merck KGaA
• Samsung Biologics
• Sartorius AG
• Eurofins Scientific
• SGS Société Générale de Surveillance SA
• Thermo Fisher Scientific Inc.
• BIOMÉRIEUX
• Lonza

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

GRNA Market to Expand with Significant CAGR During 2024– 2030: Grand View Research Inc.

 gRNA Market Growth & Trends

The global gRNA market size is anticipated to reach USD 1.62 billion by 2030 and it is projected to grow at a CAGR of 18.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising adoption of Next-Generation Sequencing (NGS) is significantly boosting the market. As NGS technologies become more prevalent, they empower researchers and scientists with advanced capabilities for genomic analysis and manipulation. NGS enables high-throughput sequencing of genetic material, allowing for the rapid and cost-effective examination of entire genomes. This efficiency is crucial for gRNA applications, as it facilitates the identification and validation of target genes for genetic manipulation. NGS technologies provide a precise and comprehensive understanding of genomic sequences. This precision is vital for designing gRNAs with high specificity, ensuring accurate targeting of genes during the gene editing process using CRISPR/Cas systems.

Furthermore, the increasing investments by biotechnology and pharmaceutical companies for R&D activities are expected to fuel the market in the coming years. The development of user-friendly and affordable gRNA synthesis kits and services has made CRISPR-Cas9 technology more accessible to researchers of all levels. The continuous discovery of novel applications for CRISPR-Cas9 fuels the demand for gRNA.

Additionally, the launch of new gRNA final products can drive innovation, expand the market reach of players, and accelerate the adoption of gene editing technologies, contributing to the overall growth & advancement of the market. For instance, in October 2023, Synthego, a prominent provider of genome engineering solutions, launched IND-enabling (INDe) gRNAs. This transformative offering marks a significant advancement in the CRISPR-based cell and gene therapy preclinical pipeline. By providing researchers with high-quality gRNAs meticulously designed for GLP-regulated preclinical and IND-enabling studies, this product incorporates comprehensive IND-compliant materials and documentation throughout its design and production. Thus, it will drive the market growth.

Request a free sample copy or view report summary: gRNA Market Report

gRNA Market Report Highlights

• On the basis of product & services, the product segment accounted for the largest revenue share of 73.4% in 2023. These products offer high accuracy, efficiency, and specificity in gene editing, making them popular among researchers is one of the primary drivers driving market expansion
• On the basis of gRNA type, the research-use segment dominated the market share in 2023. A large number of research programs conducted across various research institutes demand research-grade gRNA is driving up demand for this segment
• On the basis of application, the genome engineering segment dominated the market share in 2023. This growth can be attributed to the increasing demand for advanced genetic tools for research and therapeutic purposes
• On the basis of end-use, the pharmaceutical & biotechnology companies segment dominated the market share in 2023. The adoption of gRNA in precision medicine by pharmaceutical and biotech companies fuels its market growth as it becomes integral to the development of personalized therapies
• North America dominated the global industry in 2023 with a revenue share of 52.6% owing to the presence of key market players in the region. The majority of the key companies in this region have been actively involved in R&D activities involving gRNA

Access Press Release@ https://www.grandviewresearch.com/press-release/global-grna-market

gRNA Market Segmentation

Grand View Research has segmented the global gRNA market based on product & services, gRNA type, application, end-use, and region.

gRNA Product & Services Outlook (Revenue, USD Million, 2018 - 2030)

• Products
  • gRNA Final Products
  • gRNA Synthesis Products
    • gRNA Synthesis Kits
    • Plasmids
    • Others
  • Custom gRNA Synthesis Services

gRNA Type Outlook (Revenue, USD Million, 2018 - 2030)

• Research-Use
• GMP-grade

gRNA Application Outlook (Revenue, USD Million, 2018 - 2030)

• Genome Engineering
• Disease Model Studies
• Functional Genomics
• Epigenetics
• Others

gRNA End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies
• Academic Research Institutes
• CMOs & CROs

gRNA Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the gRNA Market

• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• System Biosciences, LLC.
• Jena Bioscience GmbH
• Merck KGaA
• GENEWIZ (Azenta Life Sciences)
• Takara Bio Inc.
• Synbio Technologies
• Horizon Discovery Ltd.
• Synthego

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Asia Pacific Immunohistochemistry Market is Likely To Touch $837.57 Million by 2030: Grand View Research Inc.

 Asia Pacific Immunohistochemistry Market Growth & Trends

The Asia Pacific immunohistochemistry market is anticipated to reach USD 837.57 million by 2030 and is projected to grow at a CAGR of 8.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the increasing prevalence of chronic diseases, growing geriatric population, and rising healthcare spending. Moreover, technological advancements in disease diagnosis procedures and techniques are further propelling the growth of the overall Asia Pacific market.

The government and key organizations constantly undertake activities intended to curb cancer-related healthcare expenditure by encouraging patients to undergo regular diagnostic examinations. For instance, in February 2023, Japan International Cooperation Agency (JICA) signed an agreement with the Indian government to extend an ODA loan of above USD 66 million for development of a super-specialty cancer and research center in Mizoram, India. Moreover, in May 2023, Fujitsu conducted a research project in association with Takeda Pharmaceutical Company Limited and the National Cancer Center Japan to analyze the process of recognition, diagnosis, and treatment of ovarian cancer patients. Such favorable initiatives undertaken by government bodies and market players are expected to support the Asia Pacific immunohistochemistry industry growth.

Moreover, aging is associated with a greater risk of infections and autoimmune diseases due to a weakened immune system. According to National Council on Aging's 2023 statistics, an estimated 95% of older people suffer from at least one chronic disease, such as cancer, heart disease, diabetes, or infectious diseases, and 80% suffer from at least two. Incidence of cancer increases 11-fold for people above 65 years of age in comparison with people below 65 years, as per European Society for Medical Oncology. Immunohistochemistry plays a vital role in disease diagnosis and treatment planning. Thus, the rise in the geriatric population is expected to increase the need for immunohistochemistry techniques.

However, the high cost associated with automated immunohistochemistry instruments poses a significant challenge in pathology and biomedical research. These instruments, designed to enhance efficiency and reproducibility, come with substantial upfront expenses. Initial acquisition cost includes instrument, software, and necessary accessories, making it a financial barrier for smaller laboratories. For instance, an advanced immunohistochemistry instrument costs around USD 85,000 to USD 90,000, which poses a high burden on hospitals and diagnostic laboratories in developing economies.

Request a free sample copy or view report summary: Asia Pacific Immunohistochemistry Market Report

Asia Pacific Immunohistochemistry Market Report Highlights

• Based on product, antibodies dominated the product segment with more than 41.5% share in 2023 owing to their significant use in disease diagnosis and research applications
• Based on application, research application segment is expected to grow at the fastest CAGR over the forecast period
• In terms of end use, hospitals and diagnostic laboratories segment held the largest share of the Asia Pacific market in 2023. Increase in the number of cancer cases is a significant factor driving the growth of this segment
• In terms of end use, research institutes segment is expected to grow at the fastest CAGR over the forecast period owing to rising research and development activities
• Japan dominated the Asia Pacific market owing to factors such as the increasing prevalence of cancer, high purchasing power parity, government support for quality healthcare, and availability of reimbursement
• In August 2023, Bio-Rad Laboratories, Inc. launched StarBright Red Dye and expanded its range of antibody markers conjugated to StarBright Dyes which now includes 29 additional cow, dog, human, mouse, and pig targets

Access Press Release@ https://www.grandviewresearch.com/press-release/asia-pacific-immunohistochemistry-market-analysis

Asia Pacific Immunohistochemistry Market Segmentation

Grand View Research has segmented the Asia Pacific immunohistochemistry market based on product, application, end-use, and country:

Asia Pacific Immunohistochemistry Product Outlook (Revenue, USD Million, 2018 - 2030)

• Antibodies
  • Primary Antibodies
  • Secondary Antibodies
• Reagents
  • Histological Stains
  • Blocking Sera and Reagents
  • Chromogenic Substrates
  • Fixation Reagents
  • Organic Solvents
  • Proteolytic Enzymes
  • Diluents
  • Other Reagents
• Equipment
  • Slide Staining Systems
  • Tissue Microarrays
  • Tissue Processing Systems
  • Slide Scanners
  • Others
• Kits

Asia Pacific Immunohistochemistry Application Outlook (Revenue, USD Million, 2018 - 2030)

• Diagnostics
  • Cancer
  • Infectious Diseases
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Diabetes Mellitus
  • Nephrological Diseases
  • Others
• Research

Asia Pacific Immunohistochemistry End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals and Diagnostic Laboratories
• Research Institutes
• Others

Asia Pacific Immunohistochemistry Regional Outlook (Revenue, USD Million, 2018 - 2030)

• Japan
• China
• India
• South Korea
• Australia
• Singapore
• Thailand
• Malaysia
• Indonesia
• Philippines
• Vietnam

List of Key Players in the Asia Pacific Immunohistochemistry Market

• Thermo Fisher Scientific Inc.
• Hoffmann-La Roche Ltd.
• Merck KGaA
• Danaher Corporation
• PerkinElmer, Inc.
• Bio-Rad Laboratories, Inc.
• Cell Signaling Technology, Inc.
• Bio SB
• Agilent Technologies, Inc.
• Abcam plc.
• HiMedia Laboratories
• IMGENEX INDIA Pvt. Ltd.
• Sino Biological, Inc.
• NICHIREI BIOSCIENCES INC. (NICHIREI CORPORATION)
• MEDICAL & BIOLOGICAL LABORATORIES CO., LTD.
• Immuno-Biological Laboratories Co, Ltd.
• Kyowa Kirin Co., Ltd.
• Amos Scientific PTY. LTD.
• PathnSitu Biotechnologies Pvt Ltd

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.